Prediction of gestational diabetes mellitus in the first trimester: Comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 16, 2015, Pages 1957-1962

  Ozgu Erdinc, A Seval ^a   Yilmaz, Saynur ^a   Yeral, M Ilkin ^a   Seckin, K Doga ^a   Erkaya, Salim ^a   Danisman, A Nuri ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Fasting plasma glucose; gestational diabetes mellitus; high sensitivity C reactive protein; homeostatic model assessment; insulin

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ACCURACY; ADULT; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WOMEN'S HEALTH; ADOLESCENT; BLOOD; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; DIABETES, GESTATIONAL; EVALUATION STUDY; FOLLOW UP; INSULIN RESISTANCE; METABOLISM; ODDS RATIO; PREGNANCY; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DECISION SUPPORT TECHNIQUES; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84942739500     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.973397     Document Type: Article

References (39)

1. Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol 1996; 36: 239-47
2. Group HSCR, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
3. Yogev C, Hod C, Oats M, et al.; Hyperglycemia, Adverse Pregnancy Outcome Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 2010; 202: 255 e251-57
4. Crowther CA, Hiller JE, Moss JR, et al.; Australian Carbohydrate Intolerance Study in Pregnant Women Trial G. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-86
5. Landon MB, Spong CY, Thom E, et al.; Eunice Kennedy Shriver National Institute of Child H, Human Development Maternal-Fetal Medicine Units N. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339-48
6. Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011; 31: 135-41
7. Maged AM, Moety GA, Mostafa WA, Hamed DA. Comparative study between different biomarkers for early prediction of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2014; 27: 1108-12
8. Yeral MI, Ozgu-Erdinc AS, Uygur D, et al. Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 2014; 46: 512-18
9. Nahum GG, Wilson SB, Stanislaw H. Early-pregnancy glucose screening for gestational diabetes mellitus. J Reprod Med 2002; 47: 656-62
10. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24: 1602-7
11. Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 2011;118:751-3
12. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-73
13. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36: S11-66
14. Hosker JP, Matthews DR, Rudenski AS, et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 1985; 28: 401-11
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19
16. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10
17. Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet 2005; 346: 120-21
18. Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80
19. Faul F, Erdfelder E, Lang AG, Buchner A. G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91
20. Di Cianni G, Miccoli R, Volpe L, et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003; 19: 259-70
21. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-13
22. Grewal E, Kansara S, Kachhawa G, et al. Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester insulin sensitivity indices in Asian Indian subjects. Metabolism 2012; 61: 715-20
23. Yachi Y, Tanaka Y, Anasako Y, et al. Contribution of first trimester fasting plasma insulin levels to the incidence of glucose intolerance in later pregnancy: Tanaka women's clinic study. Diabetes Res Clin Pract 2011; 92: 293-8
24. Bito T, Foldesi I, Nyari T, Pal A. Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy. Diabet Med 2005; 22: 1434-9
25. Ozcimen EE, Uckuyu A, Ciftci FC, et al. Diagnosis of gestational diabetes mellitus by use of the homeostasis model assessment-insulin resistance index in the first trimester. Gynecol Endocrinol 2008; 24: 224-9
26. Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008; 45: 157-65
27. Lopez Caudana AE, Lopez Ridaura R, Gonzalez Villalpando C, et al. Prediction of alterations in glucose metabolism by glucose and insulin measurements in early pregnancy. Arch Med Res 2011; 42: 70-6
28. Jiwani A, Marseille E, Lohse N, et al. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012; 25: 600-10
29. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-72
30. Catalano PM, Tyzbir ED, Wolfe RR, et al. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol 1992; 167: 913-19
31. Xiang AH, Peters RK, Trigo E, et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 1999; 48: 848-54
32. Homko C, Sivan E, Chen X, et al. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 568-73
33. Saisho Y, Miyakoshi K, Tanaka M, et al. Beta cell dysfunction and its clinical significance in gestational diabetes. Endocr J 2010; 57: 973-80
34. Nunes VA, Portioli-Sanches EP, Rosim MP, et al. Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism. J Endocrinol 2014; 221: 273-84
35. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004; 18: 377-84
36. Riskin-Mashiah S, Damti A, Younes G, Auslender R. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2010; 152: 163-7
37. Savvidou M, Nelson SM, Makgoba M, et al. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010; 59: 3017-22
38. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82
39. Wolf M, Sandler L, Hsu K, et al. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26: 819-24